On Dec. 15, 2021, the U.S. Securities and Exchange Commission (SEC or Commission) proposed Rule 240.9j-1 (the Rule), intended “to prevent fraud, manipulation, and deception in.
The U.S. Supreme Court heard arguments this week in a case seeking to limit EPA’s authority to regulate greenhouse gas (“GHG”) emissions. The principal issue in West Virginia v. EPA is.
The Court’s decision alters the landscape for claims qualifying for the No Surprises Act’s Federal IDRP, an arbitration process designed to resolve certain reimbursement disputes between commercial payors and out-of-network health care providers or emergency facilities.
On February 23, 2022, in the case captioned Texas Med. Ass’n v. U.S. Dep’t of Health & Human Servs., No. 6:21-cv-00425-JDK (E.D. Tex.), the U.S. District Court for the Eastern District.
A federal court in Delaware recently determined that the Health Resources and Services Administration (HRSA) – the federal agency responsible for administering the 340B drug pricing.